Keywords: واکسن اصلاح شده آنکارا; MVA; Modified vaccinia Ankara; rMVA; Recombinant MVA; CEF; Chicken embryo fibroblast; TG; Transgene; FACS; Fluorescence activated cell sorting; TPG; Transfer plasmid green; MCS; Multiple cloning site; P2A; Peptide 2A;
مقالات ISI واکسن اصلاح شده آنکارا (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: واکسن اصلاح شده آنکارا; Vaccinia; Smallpox vaccine; Susceptible population; Bioterrorism; Lister; Modified vaccinia Ankara; SAE; severe adverse events; EV; eczema vaccinatum; PV; progressive vaccinia; AD; atopic dermatitis; US; United States; IMOH; Israel Ministry of Health; IDF
Keywords: واکسن اصلاح شده آنکارا; AIDS; acquired immunodeficiency syndrome; BD; Becton Dickinson immunocytometry systems; Bp; base pair; CMV; cytomegalovirus; CTL; cytotoxic T lymphocytes; DNA; deoxyribonucleic acid; HIV; human immunodeficiency virus; INV; involucrin; K; keratin; MMP-9; m
Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses
Keywords: واکسن اصلاح شده آنکارا; Vaccine; Gold nanoparticles (GNPs); HIV-1; CMV; High-mannoside-type oligosaccharides; Cellular immunity; AIDS; Acquired immune deficiency syndrome; CFSE; Carboxyfluorescein diacetate succinimidyl ester; CMV; Cytomegalovirus; CTL; Citolytic T lymphocyte; D
Recent advances in the study of live attenuated cell-cultured smallpox vaccine LC16m8
Keywords: واکسن اصلاح شده آنکارا; LC16m8; Smallpox vaccine; Anti-terrorism; Monkeypox; EEV; extracellular enveloped virion; PRNT; plaque reduction neutralization titer; GMT; geometric mean titers; IMV; intracellular mature virion; PFU; plaque forming unit; WR; Western Reserve; MVA; Modifi
Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014
Keywords: واکسن اصلاح شده آنکارا; ADCC; antibody-dependent cell-mediated cytotoxicity; CMI; cell-mediated immunity; COBRA; computationally optimized broadly reactive antigen; CoP; immune correlate of protection; HA; influenza haemagglutinin protein; HI; haemagglutination inhibition; IFN;
Developing aerosol vaccines for Mycobacterium tuberculosis: Workshop proceedings
Keywords: واکسن اصلاح شده آنکارا; AM; arabinomannan; BAL; bronchoalveolar lavage; BCG; Bacille Calmette-Guérin; CFU; colony-forming units; CBER; center for biologics evaluation and research; CDRH; center for devices and radiological health; CMs; cynomolgus macaques; DPI; dry powder inhal
Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge
Keywords: واکسن اصلاح شده آنکارا; African horse sickness; Vaccine; Modified vaccinia Ankara; VP2; Protection;
Efficacy of Immunotherapy With TG4040, Peg-Interferon, and Ribavirin in a Phase 2 Study of Patients With Chronic HCV Infection
Keywords: واکسن اصلاح شده آنکارا; Vaccine; ELISpot; Immune Response; SVR24; AE; adverse event; cEVR; complete early virologic response; ETR; end of treatment; HCV; hepatitis C virus; ITT; intent-to-treat; LOD; limit of detection; MVA; modified vaccinia Ankara; PBMC; peripheral blood monon
Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice
Keywords: واکسن اصلاح شده آنکارا; Influenza; Modified vaccinia Ankara; Vaccine; Cross-protective immunity; Safety;
Estimated size of the population at risk of severe adverse events after smallpox vaccination in Israel
Keywords: واکسن اصلاح شده آنکارا; AIDS; acquired immune deficiency syndrome; CDC; Centers for Disease Control; HIV; human immunodeficiency virus; HMO; Health Maintenance Organization; MVA; modified vaccinia Ankara; VIG; vaccinia immune globulin; WHO; World Health Organization; Smallpox va
Engineering recombinant poxviruses using a compact GFP–blasticidin resistance fusion gene for selection
Keywords: واکسن اصلاح شده آنکارا; VACV, vaccinia virus; MVA, Modified Vaccinia Ankara; ECTV, ectromelia virusPoxvirus; Vaccinia virus; Modified Vaccinia Ankara; Ectromelia virus; Recombinant vaccine; Transient dominant selection
Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching
Keywords: واکسن اصلاح شده آنکارا; VACV; vaccinia virus; MVA; Modified Vaccinia Ankara; WR; Western Reserve; CEF; chick embryo fibroblasts; MOI; multiplicity of infection; NK; natural killer; i.n.; intranasal; i.m.; intramuscular; pi; post infection; Poxvirus; Antibody; T lymphocyte;
Uptake of antigens from modified vaccinia Ankara virus-infected leukocytes enhances the immunostimulatory capacity of dendritic cells
Keywords: واکسن اصلاح شده آنکارا; allogeneic stem cell transplantation; antigen-presenting cells; dendritic cells; modified vaccinia Ankara; vaccine
A Poxvirus Vaccine Is Safe, Induces T-Cell Responses, and Decreases Viral Load in Patients With Chronic Hepatitis C
Keywords: واکسن اصلاح شده آنکارا; Therapeutic Vaccine; Virology; Liver Disease; Immunity; ADR; adverse drug reaction; AE; adverse event; ALT; serum alanine aminotransferase; CEF; Cytomegalovirus, EBV, Flue; CHC; chronic hepatitis C; IFN; interferon; IL; interleukin; MVA; Modified Vaccinia
Recombinant A27 protein synergizes with modified vaccinia Ankara in conferring protection against a lethal vaccinia virus challenge
Keywords: واکسن اصلاح شده آنکارا; A27 protein; Modified vaccinia Ankara; Smallpox vaccine
Intergenic region 3 of modified vaccinia ankara is a functional site for insert gene expression and allows for potent antigen-specific immune responses
Keywords: واکسن اصلاح شده آنکارا; Modified vaccinia Ankara; Recombinant vaccine; Insertion site; Deletion site; Intergenic region; Stability
Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice
Keywords: واکسن اصلاح شده آنکارا; Yersinia pestis; Plague; Mice; Vaccines; Modified vaccinia Ankara
Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines
Keywords: واکسن اصلاح شده آنکارا; Poxvirus; Modified Vaccinia Ankara; Vaccine; Herpesvirus; Cellular immunity;
Electrocardiography Screening for Cardiotoxicity after Modified Vaccinia Ankara Vaccination
Keywords: واکسن اصلاح شده آنکارا; Early repolarization; Electrocardiography; Modified Vaccinia Ankara; Myopericarditis; Smallpox vaccine
Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine
Keywords: واکسن اصلاح شده آنکارا; Smallpox vaccine; Vaccine immunogenicity; Vaccine protection; Modified Vaccinia Ankara; Vaccinia virus
Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine
Keywords: واکسن اصلاح شده آنکارا; Smallpox vaccine; Vaccinia; MVA; Modified vaccinia Ankara; Smallpox; Variola;
The attenuation of vaccinia Tian Tan strain by the removal of the viral M1L-K2L genes
Keywords: واکسن اصلاح شده آنکارا; VTT; vaccinia Tian Tan; MVTT; modified vaccinia Tian Tan; MVA; modified vaccinia Ankara; GFP; green fluorescent protein; AIDS; acquired immunodeficiency syndrome; HIV-1; human immunodeficiency virus type one; SIV; simian immunodeficiency virus; SHIV; simi
The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection
Keywords: واکسن اصلاح شده آنکارا; Smallpox; Vaccines; Defective vaccinia; Modified vaccinia Ankara; Ectromelia; Cowpox;